11-17476848-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000644472.1(ABCC8):​n.-72G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00566 in 1,260,076 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 18 hom. )

Consequence

ABCC8
ENST00000644472.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.905

Publications

0 publications found
Variant links:
Genes affected
ABCC8 (HGNC:59): (ATP binding cassette subfamily C member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a modulator of ATP-sensitive potassium channels and insulin release. Mutations in the ABCC8 gene and deficiencies in the encoded protein have been observed in patients with hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder of unregulated and high insulin secretion. Mutations have also been associated with non-insulin-dependent diabetes mellitus type II, an autosomal dominant disease of defective insulin secretion. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
ABCC8 Gene-Disease associations (from GenCC):
  • hyperinsulinemic hypoglycemia, familial, 1
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • diabetes mellitus, permanent neonatal 3
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • familial hyperinsulinism
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • diabetes mellitus
    Inheritance: SD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • monogenic diabetes
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hypoglycemia, leucine-induced
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • diabetes mellitus, transient neonatal, 2
    Inheritance: Unknown, AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • pulmonary arterial hypertension
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant hyperinsulinism due to SUR1 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • DEND syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive hyperinsulinism due to SUR1 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • type 2 diabetes mellitus
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 11-17476848-C-T is Benign according to our data. Variant chr11-17476848-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 303791.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00423 (643/151880) while in subpopulation AMR AF = 0.00892 (136/15252). AF 95% confidence interval is 0.0077. There are 6 homozygotes in GnomAd4. There are 286 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD,Unknown,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC8NM_000352.6 linkc.-72G>A upstream_gene_variant ENST00000389817.8 NP_000343.2 Q09428-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC8ENST00000389817.8 linkc.-72G>A upstream_gene_variant 1 NM_000352.6 ENSP00000374467.4 Q09428-1

Frequencies

GnomAD3 genomes
AF:
0.00424
AC:
643
AN:
151772
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00893
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000573
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00596
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.0110
AC:
110
AN:
9982
AF XY:
0.0108
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0920
Gnomad ASJ exome
AF:
0.0833
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000380
Gnomad NFE exome
AF:
0.0181
Gnomad OTH exome
AF:
0.0373
GnomAD4 exome
AF:
0.00585
AC:
6483
AN:
1108196
Hom.:
18
Cov.:
30
AF XY:
0.00580
AC XY:
3070
AN XY:
529068
show subpopulations
African (AFR)
AF:
0.00113
AC:
25
AN:
22196
American (AMR)
AF:
0.0110
AC:
87
AN:
7938
Ashkenazi Jewish (ASJ)
AF:
0.00859
AC:
119
AN:
13856
East Asian (EAS)
AF:
0.0000398
AC:
1
AN:
25112
South Asian (SAS)
AF:
0.00370
AC:
101
AN:
27264
European-Finnish (FIN)
AF:
0.000876
AC:
28
AN:
31954
Middle Eastern (MID)
AF:
0.00574
AC:
17
AN:
2962
European-Non Finnish (NFE)
AF:
0.00624
AC:
5819
AN:
933140
Other (OTH)
AF:
0.00653
AC:
286
AN:
43774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
350
700
1050
1400
1750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00423
AC:
643
AN:
151880
Hom.:
6
Cov.:
33
AF XY:
0.00385
AC XY:
286
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41512
American (AMR)
AF:
0.00892
AC:
136
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00923
AC:
32
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.000573
AC:
6
AN:
10468
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00597
AC:
405
AN:
67888
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
32
64
96
128
160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00475
Hom.:
0
Bravo
AF:
0.00499

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 20, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hyperinsulinism, Dominant/Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Maturity onset diabetes mellitus in young Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a response to sulfonylureas. However, no association is found between this particular variant (rs541244107) of ABCC8 gene and MODY yet. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Permanent neonatal diabetes mellitus Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Transient Neonatal Diabetes, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
14
DANN
Benign
0.97
PhyloP100
0.91
PromoterAI
0.082
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs541244107; hg19: chr11-17498395; API